BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 14574462)

  • 1. RNA silencing of rotavirus gene expression.
    Arias CF; Dector MA; Segovia L; López T; Camacho M; Isa P; Espinosa R; López S
    Virus Res; 2004 Jun; 102(1):43-51. PubMed ID: 15068879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi-based drug design: considerations and future directions.
    Tang Q; Khvorova A
    Nat Rev Drug Discov; 2024 May; 23(5):341-364. PubMed ID: 38570694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral RNAi for Gene Silencing in Mosquitoes: From the Bench to the Field.
    Mysore K; Hapairai LK; Realey JS; Sun L; Roethele JB; Duman-Scheel M
    Cold Spring Harb Protoc; 2022 Jul; 2022(7):Pdb.top107690. PubMed ID: 35135890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA interference in the era of nucleic acid therapeutics.
    Jadhav V; Vaishnaw A; Fitzgerald K; Maier MA
    Nat Biotechnol; 2024 Mar; 42(3):394-405. PubMed ID: 38409587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?
    Grimm D; Kay MA
    J Clin Invest; 2007 Dec; 117(12):3633-41. PubMed ID: 18060021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer biology functional genomics: From small RNAs to big dreams.
    Sundara Rajan S; Ludwig KR; Hall KL; Jones TL; Caplen NJ
    Mol Carcinog; 2020 Dec; 59(12):1343-1361. PubMed ID: 33043516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomously folded α-helical lockers promote RNAi.
    Guyader CP; Lamarre B; De Santis E; Noble JE; Slater NK; Ryadnov MG
    Sci Rep; 2016 Oct; 6():35012. PubMed ID: 27721465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper-mediated siRNA activation for conditional control of gene expression.
    Morihiro K; Tomida Y; Ando H; Okamoto A
    Bioorg Med Chem Lett; 2024 May; 104():129738. PubMed ID: 38593925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Type Impacts Accessibility of mRNA to Silencing by RNA Interference.
    Ferguson CM; Echeverria D; Hassler M; Ly S; Khvorova A
    Mol Ther Nucleic Acids; 2020 Sep; 21():384-393. PubMed ID: 32650236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Programmable siRNA pro-drugs that activate RNAi activity in response to specific cellular RNA biomarkers.
    Han SP; Scherer L; Gethers M; Salvador AM; Salah MBH; Mancusi R; Sagar S; Hu R; DeRogatis J; Kuo YH; Marcucci G; Das S; Rossi JJ; Goddard WA
    Mol Ther Nucleic Acids; 2022 Mar; 27():797-809. PubMed ID: 35116191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi induced gene silencing in crop improvement.
    Sinha SK
    Physiol Mol Biol Plants; 2010 Dec; 16(4):321-32. PubMed ID: 23572982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNAi technique, how far is it from pediatrics?
    Zhaori G
    Pediatr Investig; 2017 Dec; 1(1):40-46. PubMed ID: 32851217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to a review series on RNA therapeutics in hematology.
    Gotlib J
    Blood; 2023 Nov; 142(19):1577-1579. PubMed ID: 37944179
    [No Abstract]   [Full Text] [Related]  

  • 14. Multidrug resistance protein 4/ ATP binding cassette transporter 4: a new potential therapeutic target for acute myeloid leukemia.
    Copsel S; Bruzzone A; May M; Beyrath J; Wargon V; Cany J; Russel FG; Shayo C; Davio C
    Oncotarget; 2014 Oct; 5(19):9308-21. PubMed ID: 25301721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogenic fusion protein RUNX1-CBFA2T1 supports proliferation and inhibits senescence in t(8;21)-positive leukaemic cells.
    Martinez N; Drescher B; Riehle H; Cullmann C; Vornlocher HP; Ganser A; Heil G; Nordheim A; Krauter J; Heidenreich O
    BMC Cancer; 2004 Aug; 4():44. PubMed ID: 15298716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient RNA interference depends on global context of the target sequence: quantitative analysis of silencing efficiency using Eulerian graph representation of siRNA.
    Pancoska P; Moravek Z; Moll UM
    Nucleic Acids Res; 2004; 32(4):1469-79. PubMed ID: 14993466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference (RNAi) in hematology.
    Scherr M; Steinmann D; Eder M
    Ann Hematol; 2004 Jan; 83(1):1-8. PubMed ID: 14574462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of gene expression by siRNA in hematopoietic cells.
    Scherr M; Eder M
    Curr Opin Drug Discov Devel; 2005 Mar; 8(2):262-9. PubMed ID: 15782549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RNA interference for the identification of disease-associated genes.
    Nencioni A; Sandy P; Dillon C; Kissler S; Blume-Jensen P; Van Parijs L
    Curr Opin Mol Ther; 2004 Apr; 6(2):136-40. PubMed ID: 15195924
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.